Header Logo

Connection

IVAN ROSAS to Antimetabolites

Back to Details
This is a "connection" page, showing publications IVAN ROSAS has written about Antimetabolites.
IVAN ROSAS
Connection Strength
0.743
Antimetabolites
  1. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270.
    View in: PubMed
    Score: 0.743
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.